| scholarly article | Q13442814 |
| P50 | author | Inge C Gyssens | Q100504905 |
| Lorna E T Stearne | Q114531592 | ||
| P2093 | author name string | Johan W Mouton | |
| Wil H F Goessens | |||
| Nicole Lemmens | |||
| Doret van Boxtel | |||
| P2860 | cites work | Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate | Q24564458 |
| Enterobacter spp.: pathogens poised to flourish at the turn of the century | Q24683746 | ||
| Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections | Q33649676 | ||
| Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996 | Q33744593 | ||
| Concentration-dependent selection of small phenotypic differences in TEM beta-lactamase-mediated antibiotic resistance | Q33980535 | ||
| In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model | Q33982034 | ||
| Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae | Q33983667 | ||
| Effect of a single percutaneous abscess drainage puncture and imipenem therapy, alone or in combination, in treatment of mixed-infection abscesses in mice | Q34252679 | ||
| Development and spread of bacterial resistance to antimicrobial agents: an overview. | Q34347837 | ||
| Efflux in bacteria: what do we really know about it? | Q34481613 | ||
| Cephalosporins in surgical prophylaxis | Q34590061 | ||
| New perspectives in antibiotic prophylaxis for intra-abdominal surgery | Q34626543 | ||
| Mechanism of suppression of piperacillin resistance in enterobacteria by tazobactam | Q34743287 | ||
| Correlation of pharmacodynamic parameters of five beta-lactam antibiotics with therapeutic efficacies in an animal model | Q35129635 | ||
| Prevalence of outer membrane porin alteration in beta-lactam-antibiotic-resistant Enterobacter aerogenes | Q35130345 | ||
| In vitro activity of trovafloxacin against Bacteroides fragilis in mixed culture with either Escherichia coli or a vancomycin- resistant strain of Enterococcus faecium determined by an anaerobic time-kill technique | Q39475998 | ||
| Pharmacokinetics of ceftizoxime in animals after parenteral dosing | Q40281398 | ||
| Anaerobes in polymicrobial surgical infections: incidence, pathogenicity, and antimicrobial resistance | Q40393939 | ||
| beta-Lactam resistance amongst Enterobacter species | Q40736310 | ||
| Beta-lactam resistance in anaerobic bacteria: a review | Q41134735 | ||
| Resistance to beta-lactam antibiotics in Bacteroides spp. | Q41664337 | ||
| A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital | Q43552304 | ||
| How predictable is development of resistance after beta-lactam therapy in Enterobacter cloacae infection? | Q43678332 | ||
| Relationship between antibiotic consumption and frequency of antibiotic resistance of four pathogens--a seven-year survey | Q43791642 | ||
| Selection of cefoxitin-resistant bacteroides thetaiotaomicron mutants and mechanisms involved in beta-lactam resistance | Q44098407 | ||
| Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species | Q45138017 | ||
| Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections. | Q50974044 | ||
| Rapid method of extraction and analysis of extended-spectrum beta-lactamases from clinical strains of Klebsiella pneumoniae. | Q53711003 | ||
| An antibiotic policy to prevent emergence of resistant bacilli. | Q54055341 | ||
| Variation in induction of chromosomal beta-lactamase expression in strains of Enterobacter cloacae. | Q54306332 | ||
| Interactions of tazobactam and clavulanate with inducibly- and constitutively-expressed Class I beta-lactamases. | Q54331490 | ||
| Development of beta-lactam-resistant Enterobacter cloacae in mice. | Q54402410 | ||
| Development of resistance during ceftazidime and cefepime therapy in a murine peritonitis model | Q68195408 | ||
| Comparative efficacies of ticarcillin, ticarcillin/clavulanic acid, piperacillin and cefoxitin against polymicrobial infections in mice caused by Escherichia coli and Bacteroides fragilis | Q70188957 | ||
| Disposition kinetics and bioavailability of piperacillin and cephapirin in mares | Q70953035 | ||
| Broad-spectrum beta-lactam resistance in Enterobacter: emergence during treatment and mechanisms of resistance | Q70986862 | ||
| Effects of Tazobactam on the Frequency of the Emergence of Resistant Strains from Enterobacter cloacae, Citrobacter freundii, and Proteus vulgaris (.BETA.-Lactamase Derepressed Mutants) | Q71822281 | ||
| Intraabdominal infection: a review | Q72775265 | ||
| Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs | Q78014354 | ||
| Cephalosporinase induction and cephalosporin resistance: a longstanding misinterpretation | Q78766717 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Bacteroides fragilis | Q221817 |
| antibiotic resistance | Q380775 | ||
| Enterobacter cloacae | Q4038096 | ||
| P304 | page(s) | 1688-1698 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Comparative study of the effects of ceftizoxime, piperacillin, and piperacillin-tazobactam concentrations on antibacterial activity and selection of antibiotic-resistant mutants of Enterobacter cloacae and Bacteroides fragilis in vitro and in vivo i | |
| P478 | volume | 48 |
| Q95409426 | A Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World |
| Q26829707 | Can we prevent antimicrobial resistance by using antimicrobials better? |
| Q36095024 | Effect of dosing and dosing frequency on the efficacy of ceftizoxime and the emergence of ceftizoxime resistance during the early development of murine abscesses caused by Bacteroides fragilis and Enterobacter cloacae mixed infection |
| Q41271135 | In vitro antibacterial activity of Ibuprofen and acetaminophen |
| Q36903693 | Optimizing drug exposure to minimize selection of antibiotic resistance |
| Q42777491 | Potential activity of the purine compounds caffeine and aminophylline on bacteria |
Search more.